X-PLO₂R™ Portable Oxygen Concentrator Receives FDA Clearance

Belluscura is excited to announce that the X-PLO2R portable oxygen concentrator has been granted 510(K) clearance from the U.S. Food and Drug Administration (FDA). We are extremely proud to bring this technology to the market, in doing our part to help improve the quality of life for millions of people worldwide who suffer from chronic lung diseases, such as the Chronic Obstructive Pulmonary Disease (COPD), respiratory distress caused by COVID-19, and many other respiratory disorders.

View the full press release and continue to follow Belluscura for future updates.

 

3 replies

Trackbacks & Pingbacks

  1. My Homepage says:

    … [Trackback]

    […] Read More: belluscura.com/x-plor-portable-oxygen-concentrator-receives-fda-clearance/ […]

  2. […] “Belluscura researched the portable oxygen market and concluded that new technology could improve the quality and efficiency of oxygen concentrators while also reducing the cost to the patient and caregiver,” Robert Rauker, CEO of Belluscura, said in a press release. […]

  3. […] “Belluscura researched the portable oxygen market and concluded that new technology could improve the quality and efficiency of oxygen concentrators while also reducing the cost to the patient and caregiver,” Robert Rauker, CEO of Belluscura, said in a press release. […]

Comments are closed.